全文获取类型
收费全文 | 151篇 |
免费 | 3篇 |
国内免费 | 1篇 |
专业分类
基础医学 | 7篇 |
临床医学 | 18篇 |
内科学 | 58篇 |
神经病学 | 1篇 |
特种医学 | 1篇 |
外科学 | 63篇 |
药学 | 6篇 |
中国医学 | 1篇 |
出版年
2021年 | 2篇 |
2019年 | 2篇 |
2017年 | 1篇 |
2016年 | 2篇 |
2015年 | 3篇 |
2014年 | 11篇 |
2013年 | 8篇 |
2012年 | 10篇 |
2011年 | 7篇 |
2010年 | 8篇 |
2009年 | 3篇 |
2008年 | 10篇 |
2007年 | 17篇 |
2006年 | 12篇 |
2005年 | 14篇 |
2004年 | 14篇 |
2003年 | 7篇 |
2002年 | 2篇 |
2001年 | 3篇 |
2000年 | 2篇 |
1999年 | 2篇 |
1998年 | 1篇 |
1997年 | 1篇 |
1995年 | 2篇 |
1994年 | 2篇 |
1993年 | 2篇 |
1992年 | 2篇 |
1991年 | 4篇 |
1990年 | 1篇 |
排序方式: 共有155条查询结果,搜索用时 578 毫秒
101.
102.
The regulation of blood pressure is a complex process, involving several organs. The kidney plays a major role and is involved in the initiation and maintenance of hypertension. Mechanisms involved are: (1) the sympathetic nerveous system, (2) the renin-angiotensin system, (3) the regulation of sodium and water balance, (4) the production of vasoactive substances such as endothelin, adenosine or nitric oxide (NO), and (5) structural alterations such as a reduced number of glomeruli and nephrons.Several therapeutic intervention strategies affecting these mechanisms have already proven to be effective antihypertensive drugs. 相似文献
103.
104.
Fliser D Bahlmann FH deGroot K Haller H 《Nature clinical practice. Cardiovascular medicine》2006,3(10):563-572
The major physiological function of erythropoietin is the induction of erythropoiesis. A growing body of evidence indicates, however, that this hormone has tissue-protective effects and prevents tissue damage during ischemia and inflammation. This review article summarizes the present knowledge on the cardiovascular and renal protective effects of erythropoietin and discusses the possible underlying mechanisms. 相似文献
105.
Andreja Sinkovic David Suran Lidija Lokar Eva Fliser Mojca Skerget Zoran Novak Zeljko Knez 《Phytotherapy research : PTR》2011,25(3):402-407
Polyphenol antioxidants decrease the risk of atherosclerosis. The study aimed to evaluate prospectively in healthy young participants the effect of oral rosemary extracts (RE), consisting of diphenols, upon endothelial dysfunction (ED), preceding structural atherosclerosis. Nineteen healthy young volunteers were studied prospectively, who received oral RE (77.7 mg) for 21 days, consisting of active substances carnosol (0.97 mg), carnosic (8.60 mg) and rosmarinic acid (10.30 mg). Before and after RE treatment, the study evaluated fasting serum levels of plasminogen‐activator‐inhibitor‐1 (PAI‐1), vascular cell adhesion molecule 1 (VCAM‐1), inter‐cellular adhesion molecule 1 (ICAM‐1), superoxide dismutase (SOD), glutathione peroxidase (GPX), fibrinogen, high‐sensitivity capsular reactive protein (hs‐CRP), tumor‐necrosis factor α (TNF‐α), the lipid profile and ED, characterized as flow‐mediated dilatation (FMD) in the brachial artery of <4.5%, estimated by ultrasound measurements. After 21 days, any side effects were registered, the mean FMD increased nonsignificantly (6.51 ± 5.96% vs 7.78 ± 4.56%, p = 0.546) and ED decreased significantly (66.6% vs 16.6%, p = 0.040). Among the serum markers, only the mean PAI‐1 level decreased significantly (4.25 ± 1.46 U/mL vs 3.0 ± 0.61 U/mL, p = 0.012) after 21‐day RE supplementation. It is concluded that oral RE supplementation has the potential to improve serum PAI‐1 activity and ED in young and healthy individuals. Copyright © 2010 John Wiley & Sons, Ltd. 相似文献
106.
107.
108.
Link A Klingele M Speer T Rbah R Pöss J Lerner-Gräber A Fliser D Böhm M 《Critical care (London, England)》2012,16(3):R97-11
ABSTRACT: INTRODUCTION: Regional citrate anticoagulation is safe, feasible and increasingly used in critically ill patients on continuous renal replacement therapy (CRRT). However, in patients with hepatic or multi-organ dysfunction, citrate accumulation may lead to an imbalance of calcium homeostasis. The study aimed at evaluating the incidence and prognostic relevance of an increased total to ionized calcium ratio (T/I Ca2+ ratio) and its association to hepatic dysfunction. METHODS: We performed a prospective observational study on n = 208 critically ill patients with acute kidney injury (AKI) and necessity for CRRT with regional citrate anticoagulation (CRRT-citrate) between September 2009 and September 2011. Critical illness was estimated by Simplified Acute Physiology Score II; hepatic function was measured with indocyanine green plasma disappearance rate. After achieving a steady state of calcium homeostasis patients were classified into tertiles according to the T/I Ca2+ ratio (<2.0 versus 2.0 - 2.39 versus ≥2.4). RESULTS: The T/I Ca2+ ratio was determined as an independent predictor for 28-day mortality in critically ill patients with AKI on CRRT-citrate confirmed by receiver operating characteristics and multivariate analysis (Area under the curve 0.94 ± 0.02; p<0.001). A T/I Ca2+ ratio ≥2.4 independently predicted a 33.5-fold (p<0.001) increase in 28-day mortality-rate. There was a significant correlation between the T/I Ca2+ ratio and the hepatic clearance (p<0.001) and the severity of critical illness (p<0.001). The efficacy and safety of citrate anticoagulation, determined by blood urea nitrogen, mean filter patency and bleeding episodes, were not significantly different between the tertiles. CONCLUSIONS: In patients on CRRT-citrate T/I Ca2+ ratio is closely related to the clinical outcome and emerged as an independent predictor of 28-day mortality. Larger studies are required to define the cut-off and predictive value for the T/I Ca2+ ratio. This ratio is associated with hepatic and/or multi-organ dysfunction and therefore an important therapeutic target. 相似文献
109.
Proteomic analysis for the assessment of diabetic renal damage in humans 总被引:15,自引:0,他引:15
Mischak H Kaiser T Walden M Hillmann M Wittke S Herrmann A Knueppel S Haller H Fliser D 《Clinical science (London, England : 1979)》2004,107(5):485-495
Renal disease in patients with Type II diabetes is the leading cause of terminal renal failure and a major healthcare problem. Hence early identification of patients prone to develop this complication is important. Diabetic renal damage should be reflected by a change in urinary polypeptide excretion at a very early stage. To analyse these changes, we used an online combination of CE/MS (capillary electrophoresis coupled with MS), allowing fast and accurate evaluation of up to 2000 polypeptides in urine. Employing this technology, we have examined urine samples from 39 healthy individuals and from 112 patients with Type II diabetes mellitus and different degrees of albumin excretion rate. We established a 'normal' polypeptide pattern in the urine of healthy subjects. In patients with Type II diabetes and normal albumin excretion rate, the polypeptide pattern in urine differed significantly from normal, indicating a specific 'diabetic' pattern of polypeptide excretion. In patients with higher grade albuminuria, we were able to detect a polypeptide pattern indicative of 'diabetic renal damage'. We also found this pattern in 35% of those patients who had low-grade albuminuria and in 4% of patients with normal albumin excretion. Moreover, we could identify several of the indicative polypeptides using MS/MS sequencing. We conclude that proteomic analysis with CE/MS permits fast and accurate identification and differentiation of polypeptide patterns in urine. Longitudinal studies should explore the potential of this powerful diagnostic tool for early detection of diabetic renal damage. 相似文献